TARS R&D Expense Growth
Tarsus Pharmaceuticals Inc · R&D Expense Growth
TARS R&D Expense Growth
Latest reported20.48%period ending
TARS FY R&D Growth (YoY) (0.00% → 20.48%)
Latest values, visible window
High-resolution chart · PNG
TARS r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 20.4848% | |
| 6.1099% | |
| 18.0368% | |
| 2.1864% | |
| 121.5659% | |
| 495.3827% | |
| 250.9434% | |
| 0% |